Profil
Xavier Avat, former Head of Corporate Development at Gilead Sciences, Inc., served as the SVP of Global Corporate Strategy & New Initiatives at Edwards Lifesciences Corp.
He also held the position of Vice President of Corporate Development at Santen Pharmaceutical Co., Ltd.
In 2022-2023, Avat worked as the Chief Business Officer at Capricor Therapeutics, Inc. Avat graduated from Ecole Polytechnique Universitaire de Lille and holds an MBA from École des Hautes Études Commerciales du Nord.
Anciens postes connus de Xavier Avat
| Sociétés | Poste | Fin |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2023 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
| EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | - |
Formation de Xavier Avat
| École des Hautes Études Commerciales du Nord | Masters Business Admin |
| Ecole Polytechnique Universitaire de Lille | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
